Tailoring Particle Size of Mesoporous Silica Nanosystem to Antagonize Glioblastoma and Overcome Blood-Brain Barrier

ACS Applied Materials and Interfaces

Volumn 8, Issue 11, 2016, Pages 6811-6825

  Mo, Jianbin ^a   He, Lizhen ^a   Ma, Bin ^a   Chen, Tianfeng ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

apoptosis; BBB; glioblastoma; mesoporous silica nanosystem; particle size

Indexed keywords

BLOOD; BRAIN; CELL DEATH; CELLS; CHEMOTHERAPY; CYTOLOGY; DISEASES; ENZYME INHIBITION; MACROMOLECULES; MESOPOROUS MATERIALS; NANOPARTICLES; PARTICLE SIZE; SILICA; TISSUE; TUMORS;

ANTICANCER ACTIVITIES; BLOOD-BRAIN BARRIER; CANCER NANOTECHNOLOGY; CEREBRAL CIRCULATION; GLIOBLASTOMAS; MESOPOROUS SILICA; MESOPOROUS SILICA NANOPARTICLES; TOXIC SIDE EFFECTS;

NANOSYSTEMS;

DOXORUBICIN; DRUG CARRIER; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE;

APOPTOSIS; BLOOD BRAIN BARRIER; CHEMISTRY; DRUG EFFECTS; GLIOBLASTOMA; HUMAN; METABOLISM; PATHOLOGY; POROSITY; TUMOR CELL LINE;

APOPTOSIS; BLOOD-BRAIN BARRIER; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; GLIOBLASTOMA; HUMANS; NANOPARTICLES; POROSITY; REACTIVE OXYGEN SPECIES; SILICON DIOXIDE;

EID: 84962054071     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.5b11730     Document Type: Article

References (51)

1. Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D. M.; Forman, D.; Bray, F. Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012 Int. J. Cancer 2015, 136, E359-386 10.1002/ijc.29210
2. Haukka, J.; Sankila, R.; Klaukka, T.; Lonnqvist, J.; Niskanen, L.; Tanskanen, A.; Wahlbeck, K.; Tiihonen, J. Incidence of Cancer and Statin Usage - Record Linkage Study Int. J. Cancer 2010, 126, 279-284 10.1002/ijc.24536
3. Kast, R. E.; Boockvar, J. A.; Bruning, A.; Cappello, F.; Chang, W. W.; Cvek, B.; Dou, Q. P.; Duenas-Gonzalez, A.; Efferth, T.; Focosi, D.; Ghaffari, S. H.; Karpel-Massler, G.; Ketola, K.; Khoshnevisan, A.; Keizman, D.; Magne, N.; Marosi, C.; McDonald, K.; Munoz, M.; Paranjpe, A.; Pourgholami, M. H.; Sardi, I.; Sella, A.; Srivenugopal, K. S.; Tuccori, M.; Wang, W.; Wirtz, C. R.; Halatsch, M. E. A Conceptually New Treatment Approach for Relapsed Glioblastoma: Coordinated Undermining of Survival Paths with Nine Repurposed Drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care Oncotarget 2013, 4, 502-530 10.18632/oncotarget.969
4. Kijima, N.; Hosen, N.; Kagawa, N.; Hashimoto, N.; Nakano, A.; Fujimoto, Y.; Kinoshita, M.; Sugiyama, H.; Yoshimine, T. CD166/Activated Leukocyte Cell Adhesion Molecule is Expressed on Glioblastoma Progenitor Cells and Involved in the Regulation of Tumor Cell Invasion Neuro Oncol. 2012, 14, 1254-1264 10.1093/neuonc/nor202
5. Gaudin, A.; Tagit, O.; Sobot, D.; Lepetre-Mouelhi, S.; Mougin, J.; Martens, T. F.; Braeckmans, K.; Nicolas, V.; Desmaële, D.; de Smedt, S. C.; Hildebrandt, N.; Couvreur, P.; Andrieux, K. Transport Mechanisms of Squalenoyl-Adenosine Nanoparticles Across the Blood-Brain Barrier Chem. Mater. 2015, 27, 3636-3647 10.1021/acs.chemmater.5b00267
6. Utsuki, S.; Oka, H.; Suzuki, S.; Shimizu, S.; Tanizaki, Y.; Kondo, K.; Tanaka, S.; Kawano, N.; Fujii, K. Pathological and Clinical Features of Cystic and Noncystic Glioblastomas Brain Tumor Pathol. 2006, 23, 29-34 10.1007/s10014-006-0195-8
7. Neuwelt, E. A.; Bauer, B.; Fahlke, C.; Fricker, G.; Iadecola, C.; Janigro, D.; Leybaert, L.; Molnar, Z.; O'Donnell, M. E.; Povlishock, J. T.; Saunders, N. R.; Sharp, F.; Stanimirovic, D.; Watts, R. J.; Drewes, L. R. Engaging Neuroscience to Advance Translational Research in Brain Barrier Biology Nat. Rev. Neurosci. 2011, 12, 169-182 10.1038/nrn2995
8. Obermeier, B.; Daneman, R.; Ransohoff, R. M. Development, Maintenance and Disruption of the Blood-Brain Barrier Nat. Med. 2013, 19, 1584-1596 10.1038/nm.3407
9. Li, X. Y.; Zhao, Y.; Sun, M. G.; Shi, J. F.; Ju, R. J.; Zhang, C. X.; Li, X. T.; Zhao, W. Y.; Mu, L. M.; Zeng, F.; Lou, J. N.; Lu, W. L. Multifunctional Liposomes Loaded with Paclitaxel and Artemether for Treatment of Invasive Brain Glioma Biomaterials 2014, 35, 5591-5604 10.1016/j.biomaterials.2014.03.049
10. Gao, X.; Qian, J.; Zheng, S.; Changyi, Y.; Zhang, J.; Ju, S.; Zhu, J.; Li, C. Overcoming the Blood-Brain Barrier for Delivering Drugs into the Brain by Using Adenosine Receptor Nanoagonist ACS Nano 2014, 8, 3678-3689 10.1021/nn5003375
11. Qiao, L.; Liang, N.; Zhang, J.; Xie, J.; Liu, F.; Xu, D.; Yu, X.; Tian, Y. Advanced Research on Vasculogenic Mimicry in Cancer J. Cell. Mol. Med. 2015, 19, 315-326 10.1111/jcmm.12496
12. Chen, Y. S.; Chen, Z. P. Vasculogenic Mimicry: a Novel Target for Glioma Therapy Aizheng 2014, 33, 74-79 10.5732/cjc.012.10292
13. Liu, X.; Wang, X.; Du, W.; Chen, L.; Wang, G.; Cui, Y.; Liu, Y.; Dou, Z.; Wang, H.; Zhang, P.; Chang, L.; Yi, L.; Cai, J.; Jiang, C. Suppressor of Fused (Sufu) Represses Gli1 Transcription and Nuclear Accumulation, Inhibits Glioma Cell Proliferation, Invasion and Vasculogenic Mimicry, Improving Glioma Chemo-Sensitivity and Prognosis Oncotarget 2014, 5, 11681-11694 10.18632/oncotarget.2585
14. Mao, X. G.; Xue, X. Y.; Wang, L.; Zhang, X.; Yan, M.; Tu, Y. Y.; Lin, W.; Jiang, X. F.; Ren, H. G.; Zhang, W.; Song, S. J. CDH5 is Specifically Activated in Glioblastoma Stemlike Cells and Contributes to Vasculogenic Mimicry Induced by Hypoxia Neuro Oncol. 2013, 15, 865-879 10.1093/neuonc/not029
15. Liu, Y.; Mei, L.; Yu, Q.; Xu, C.; Qiu, Y.; Yang, Y.; Shi, K.; Zhang, Q.; Gao, H.; Zhang, Z.; He, Q. Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma ACS Appl. Mater. Interfaces 2015, 7, 16792-16801 10.1021/acsami.5b04596
16. Zhang, S.; Zhang, D.; Sun, B. Vasculogenic Mimicry: Current Status and Future Prospects Cancer Lett. 2007, 254, 157-164 10.1016/j.canlet.2006.12.036
17. Salvati, E.; Re, F.; Sesana, S.; Cambianica, I.; Sancini, G.; Masserini, M.; Gregori, M. Liposomes Functionalized to Overcome the Blood-Brain Barrier and to Target Amyloid-Beta Peptide: the Chemical Design Affects the Permeability Across an In Vitro Model Int. J. Nanomed. 2013, 8, 1749-1758 10.2147/IJN.S42783
18. Thomas, F. C.; Taskar, K.; Rudraraju, V.; Goda, S.; Thorsheim, H. R.; Gaasch, J. A.; Mittapalli, R. K.; Palmieri, D.; Steeg, P. S.; Lockman, P. R.; Smith, Q. R. Uptake of ANG1005, a Novel Paclitaxel Derivative, through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer Pharm. Res. 2009, 26, 2486-2494 10.1007/s11095-009-9964-5
19. Nie, S.; Xing, Y.; Kim, G. J.; Simons, J. W. Nanotechnology Applications in Cancer Annu. Rev. Biomed. Eng. 2007, 9, 257-288 10.1146/annurev.bioeng.9.060906.152025
20. Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges Nat. Rev. Cancer 2005, 5, 161-171 10.1038/nrc1566
21. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760 10.1038/nnano.2007.387
22. Schroeder, A.; Heller, D. A.; Winslow, M. M.; Dahlman, J. E.; Pratt, G. W.; Langer, R.; Jacks, T.; Anderson, D. G. Treating Metastatic Cancer with Nanotechnology Nat. Rev. Cancer 2012, 12, 39-50 10.1038/nrc3180
23. Ashley, C. E.; Carnes, E. C.; Phillips, G. K.; Padilla, D.; Durfee, P. N.; Brown, P. A.; Hanna, T. N.; Liu, J.; Phillips, B.; Carter, M. B.; Carroll, N. J.; Jiang, X.; Dunphy, D. R.; Willman, C. L.; Petsev, D. N.; Evans, D. G.; Parikh, A. N.; Chackerian, B.; Wharton, W.; Peabody, D. S.; Brinker, C. J. The Targeted Delivery of Multicomponent Cargos to Cancer Cells by Nanoporous Particle-Supported Lipid Bilayers Nat. Mater. 2011, 10, 389-397 10.1038/nmat2992
24. Li, C. A Targeted Approach to Cancer Imaging and Therapy Nat. Mater. 2014, 13, 110-115 10.1038/nmat3877
25. Mulvey, J. J.; Villa, C. H.; McDevitt, M. R.; Escorcia, F. E.; Casey, E.; Scheinberg, D. A. Self-Assembly of Carbon Nanotubes and Antibodies on Tumours for Targeted Amplified Delivery Nat. Nanotechnol. 2013, 8, 763-771 10.1038/nnano.2013.190
26. Slowing, I. I.; Trewyn, B. G.; Giri, S.; Lin, V. S. Y. Mesoporous Silica Nanoparticles for Drug Delivery and Biosensing Applications Adv. Funct. Mater. 2007, 17, 1225-1236 10.1002/adfm.200601191
27. Hendrix, M. J.; Seftor, E. A.; Hess, A. R.; Seftor, R. E. Molecular Plasticity of Human Melanoma Cells Oncogene 2003, 22, 3070-3075 10.1038/sj.onc.1206447
28. Sun, N. F.; Meng, Q. Y.; Tian, A. L.; Hu, S. Y.; Wang, R. H.; Liu, Z. X.; Xu, L. Nanoliposome-Mediated FL/TRAIL Double-Gene Therapy for Colon Cancer: In Vitro and In Vivo Evaluation Cancer Lett. 2012, 315, 69-77 10.1016/j.canlet.2011.10.010
29. Pankhurst, Q. A.; Connolly, J.; Jones, S. K.; Dobson, J. Applications of Magnetic Nanoparticles in Biomedicine J. Phys. D: Appl. Phys. 2003, 36, R167-R181 10.1088/0022-3727/36/13/201
30. He, Q.; Shi, J. MSN Anti-Cancer Nanomedicines: Chemotherapy Enhancement, Overcoming of Drug Resistance, and Metastasis Inhibition Adv. Mater. 2014, 26, 391-411 10.1002/adma.201303123
31. Chen, Y.; Chen, H.; Shi, J. In Vivo Bio-safety Evaluations and Diagnostic/Therapeutic Applications of Chemically Designed Mesoporous Silica Nanoparticles Adv. Mater. 2013, 25, 3144-3176 10.1002/adma.201205292
32. He, L.; Huang, Y.; Zhu, H.; Pang, G.; Zheng, W.; Wong, Y.-S.; Chen, T. Cancer-Targeted Monodisperse Mesoporous Silica Nanoparticles as Carrier of Ruthenium Polypyridyl Complexes to Enhance Theranostic Effects Adv. Funct. Mater. 2014, 24, 2754-2763 10.1002/adfm.201303533
33. He, L.; Chen, T.; You, Y.; Hu, H.; Zheng, W.; Kwong, W. L.; Zou, T.; Che, C. M. A Cancer-Targeted Nanosystem for Delivery of Gold(III) Complexes: Enhanced Selectivity and Apoptosis-Inducing Efficacy of a Gold(III) Porphyrin Complex Angew. Chem., Int. Ed. 2014, 53, 12532-12536 10.1002/anie.201407143
34. Simond, M. R.; Ballerat-Busserolles, K.; Coulier, Y.; Rodier, L.; Coxam, J. Y. Dissociation Constants of Protonated Amines in Water at Temperatures from 293.15 to 343.15 K J. Solution Chem. 2012, 41, 130-142 10.1007/s10953-011-9790-3
35. Singh, N.; Karambelkar, A.; Gu, L.; Lin, K.; Miller, J. S.; Chen, C. S.; Sailor, M. J.; Bhatia, S. N. Bioresponsive Mesoporous Silica Nanoparticles for Triggered Drug Release J. Am. Chem. Soc. 2011, 133, 19582-19585 10.1021/ja206998x
36. Lu, J.; Li, Z.; Zink, J. I.; Tamanoi, F. In Vivo Tumor Suppression Efficacy of Mesoporous Silica Nanoparticles-Based Drug-Delivery System: Enhanced Efficacy by Folate Modification Nanomedicine 2012, 8, 212-220 10.1016/j.nano.2011.06.002
37. Qiao, R.; Jia, Q.; Huwel, S.; Xia, R.; Liu, T.; Gao, F.; Galla, H.-J.; Gao, M. Receptor-Mediated Delivery of Magnetic Nanoparticles across the Blood-Brain Barrier ACS Nano 2012, 6, 3304-3310 10.1021/nn300240p
38. Liu, Y.; Ran, R.; Chen, J.; Kuang, Q.; Tang, J.; Mei, L.; Zhang, Q.; Gao, H.; Zhang, Z.; He, Q. Paclitaxel Loaded Liposomes Decorated With a Multifunctional Tandem Peptide for Glioma Targeting Biomaterials 2014, 35, 4835-4847 10.1016/j.biomaterials.2014.02.031
39. Zhan, C.; Wei, X.; Qian, J.; Feng, L.; Zhu, J.; Lu, W. Co-delivery of TRAIL Gene Enhances the Anti-Glioblastoma Effect of Paclitaxel In Vitro and In Vivo J. Controlled Release 2012, 160, 630-636 10.1016/j.jconrel.2012.02.022
40. Park, T. E.; Singh, B.; Li, H.; Lee, J. Y.; Kang, S. K.; Choi, Y. J.; Cho, C. S. Enhanced BBB Permeability of Osmotically Active Poly(mannitol-co-PEI) Modified with Rabies Virus Glycoprotein via Selective Stimulation of Caveolar Endocytosis for RNAi Therapeutics in Alzheimer's disease Biomaterials 2015, 38, 61-71 10.1016/j.biomaterials.2014.10.068
41. Liu, W.; Li, X.; Wong, Y. S.; Zheng, W.; Zhang, Y.; Cao, W.; Chen, T. Selenium Nanoparticles as a Carrier of 5-fluorouracil to Achieve Anticancer Synergism ACS Nano 2012, 6, 6578-6591 10.1021/nn202452c
42. He, L.; Lai, H.; Chen, T. Dual-Function Nanosystem for Synergetic Cancer Chemo-/Radiotherapy through ROS-Mediated Signaling Pathways Biomaterials 2015, 51, 30-42 10.1016/j.biomaterials.2015.01.063
43. Chen, T.; Wong, Y. S. Selenocystine Induces Apoptosis of A375 Human Melanoma Cells by Activating ROS-Mediated Mitochondrial Pathway and p53 Phosphorylation Cell. Mol. Life Sci. 2008, 65, 2763-2775 10.1007/s00018-008-8329-2
44. Chen, T.; Wong, Y. S. Selenocystine Induces Reactive Oxygen Species-Mediated Apoptosis in Human Cancer Cells Biomed. Pharmacother. 2009, 63, 105-113 10.1016/j.biopha.2008.03.009
45. Chen, T.; Wong, Y. S. Selenocystine Induces S-Phase Arrest and Apoptosis in Human Breast Adenocarcinoma MCF-7 Cells by Modulating ERK and Akt Phosphorylation J. Agric. Food Chem. 2008, 56, 10574-10581 10.1021/jf802125t
46. Ying, X.; Wen, H.; Lu, W. L.; Du, J.; Guo, J.; Tian, W.; Men, Y.; Zhang, Y.; Li, R. J.; Yang, T. Y.; Shang, D. W.; Lou, J. N.; Zhang, L. R.; Zhang, Q. Dual-Targeting Daunorubicin Liposomes Improve the Therapeutic Efficacy of Brain Glioma in Animals J. Controlled Release 2010, 141, 183-192 10.1016/j.jconrel.2009.09.020
47. Oberoi, R. K.; Parrish, K. E.; Sio, T. T.; Mittapalli, R. K.; Elmquist, W. F.; Sarkaria, J. N. Strategies to Improve Delivery of Anticancer Drugs Across the Blood-Brain Barrier to Treat Glioblastoma Neuro Oncol. 2016, 18, 27-36 10.1093/neuonc/nov164
48. Lee, M. H.; Kim, J. Y.; Han, J. H.; Bhuniya, S.; Sessler, J. L.; Kang, C.; Kim, J. S. Direct Fluorescence Monitoring of the Delivery and Cellular Uptake of a Cancer-Targeted RGD Peptide-Appended Naphthalimide Theragnostic Prodrug J. Am. Chem. Soc. 2012, 134, 12668-12674 10.1021/ja303998y
49. Reeves, P. M.; Kang, Y. L.; Kirchhausen, T. Endocytosis of Ligand Activated Sphingosine 1-Phosphate Receptor 1 Mediated by the Clathrin-pathway Traffic 2016, 17, 40-52 10.1111/tra.12343
50. Fan, C.; Chen, J.; Wang, Y.; Wong, Y. S.; Zhang, Y.; Zheng, W.; Cao, W.; Chen, T. Selenocystine PotentiatesCancer Cell Apoptosis Induced by 5-Fluorouracil by Triggering Reactive Oxygen Species-Mediated DNA Damage and Inactivation of the ERK Pathway Free Radical Biol. Med. 2013, 65, 305-316 10.1016/j.freeradbiomed.2013.07.002
51. Seo, J. W.; Ang, J.; Mahakian, L. M.; Tam, S.; Fite, B.; Ingham, E. S.; Beyer, J.; Forsayeth, J.; Bankiewicz, K. S.; Xu, T.; Ferrara, K. W. Self-Assembled 20-nm (64)Cu-Micelles Enhance Accumulation in Rat Glioblastoma J. Controlled Release 2015, 220, 51-60 10.1016/j.jconrel.2015.09.057